146 related articles for article (PubMed ID: 32529657)
1. Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives.
Işık M; Akocak S; Lolak N; Taslimi P; Türkeş C; Gülçin İ; Durgun M; Beydemir Ş
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000102. PubMed ID: 32529657
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.
Bilginer S; Gul HI; Anil B; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000243. PubMed ID: 32984993
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
[TBL] [Abstract][Full Text] [Related]
4. meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties.
Türker F; Barut Celepci D; Aktaş A; Taslimi P; Gök Y; Aygün M; Gülçin İ
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800029. PubMed ID: 29963738
[TBL] [Abstract][Full Text] [Related]
5. Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties.
Bilginer S; Gonder B; Gul HI; Kaya R; Gulcin I; Anil B; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):325-329. PubMed ID: 31813300
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
Lolak N; Akocak S; Bua S; Koca M; Supuran CT
Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes.
Erdoğan M; Taslimi P; Tuzun B
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000409. PubMed ID: 33666284
[TBL] [Abstract][Full Text] [Related]
9. Biology-oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors.
Ansari MA; Saad SM; Khan KM; Salar U; Taslimi P; Taskın-Tok T; Saleem F; Jahangir S
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100376. PubMed ID: 34862640
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives.
Ishaq M; Taslimi P; Shafiq Z; Khan S; Ekhteiari Salmas R; Zangeneh MM; Saeed A; Zangeneh A; Sadeghian N; Asari A; Mohamad H
Bioorg Chem; 2020 Jul; 100():103924. PubMed ID: 32442818
[TBL] [Abstract][Full Text] [Related]
11. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Istrefi Q; Türkeş C; Arslan M; Demir Y; Nixha AR; Beydemir Ş; Küfrevioğlu ÖI
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900383. PubMed ID: 32285537
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
Pedrood K; Sherafati M; Mohammadi-Khanaposhtani M; Asgari MS; Hosseini S; Rastegar H; Larijani B; Mahdavi M; Taslimi P; Erden Y; Günay S; Gulçin İ
Int J Biol Macromol; 2021 Feb; 170():1-12. PubMed ID: 33352155
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
Taslimi P
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
[TBL] [Abstract][Full Text] [Related]
16. New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
Mirzazadeh R; Asgari MS; Barzegari E; Pedrood K; Mohammadi-Khanaposhtani M; Sherafati M; Larijani B; Rastegar H; Rahmani H; Mahdavi M; Taslimi P; Üç EM; Gulçin İ
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2000471. PubMed ID: 33999440
[TBL] [Abstract][Full Text] [Related]
17. Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies.
Genc Bilgicli H; Ergon D; Taslimi P; Tüzün B; Akyazı Kuru İ; Zengin M; Gülçin İ
Bioorg Chem; 2020 Aug; 101():103969. PubMed ID: 32474181
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and discovery of potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and α-glycosidase enzymes inhibitors: The novel N,N'-bis-cyanomethylamine and alkoxymethylamine derivatives.
Taslimi P; Caglayan C; Farzaliyev V; Nabiyev O; Sujayev A; Turkan F; Kaya R; Gulçin İ
J Biochem Mol Toxicol; 2018 Apr; 32(4):e22042. PubMed ID: 29457667
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from Lawsone.
Riaz MT; Yaqub M; Shafiq Z; Ashraf A; Khalid M; Taslimi P; Tas R; Tuzun B; Gulçin İ
Bioorg Chem; 2021 Sep; 114():105069. PubMed ID: 34134033
[TBL] [Abstract][Full Text] [Related]
20. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes.
Kucukoglu K; Gul HI; Taslimi P; Gulcin I; Supuran CT
Bioorg Chem; 2019 May; 86():316-321. PubMed ID: 30743172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
